• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Steps for implantation and refill of PDS with ranibizumab

Opinion
Video

Margaret Chang, MD, outlines the steps for the surgical procedure to implant and refill the Port Delivery System (PDS).

  1. Walk through the Steps of the surgical procedure to implant and refill PDS
Related Videos
This series features 1 KOL.
This series features 1 KOL.
Video 2 - 1 KOL is featured in, "Advances in Technology for SMILE procedure"
Video 1 - 1 KOL is featured in, "Overview of Small Incision Lenticule Extraction (SMILE)"
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Related Content
FDA approves Formycon’s biosimilar to Eylea, aflibercept-mrbb (Ahzantive)

FDA approves Formycon’s biosimilar to Eylea, aflibercept-mrbb (Ahzantive)

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Podcast
Ocular Therapeutix updates on clinical developments and future plans for Axpaxli

Ocular Therapeutix updates on clinical developments and future plans for Axpaxli

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention

Podcast
Stealth BioTherapeutics enrolls first patient in global Phase 3 clinical program for elamipretide in patients diagnosed with dry AMD

Stealth BioTherapeutics enrolls first patient in global Phase 3 clinical program for elamipretide in patients diagnosed with dry AMD

Article
Avirmax Biopharma Inc receives IND approval from FDA

Avirmax Biopharma Inc receives IND approval from FDA

Article
© 2024 MJH Life Sciences

All rights reserved.